Profil
Catherine Isted is currently the Chief Financial Officer at BenevolentAI SA since 2023.
Prior to this, she was the Chief Executive Officer & Executive Director at ReNeuron Group Plc from 2021 to 2023, Head-Corporate Development & Investor Relations at Oxford Biomedica Plc from 2019 to 2021, Sales Associate at Peel Hunt LLP from 2015 to 2019, and Sales Associate at Nomura Code Securities Ltd.
from 2009 to 2013.
Postes actifs de Catherine Isted
Sociétés | Poste | Début |
---|---|---|
BENEVOLENTAI | Director of Finance/CFO | 11/09/2023 |
Anciens postes connus de Catherine Isted
Sociétés | Poste | Fin |
---|---|---|
RENEURON GROUP PLC | Chief Executive Officer | 03/01/2023 |
OXFORD BIOMEDICA PLC | Public Communications Contact | 01/10/2021 |
Peel Hunt LLP
Peel Hunt LLP Investment Banks/BrokersFinance Peel Hunt LLP is an independent securities brokerage firm headquartered in London, UK. The firm was founded in 1989 as a market liquidity provider to retail and institutional investors. They provide bespoke dealing and execution services for institutional asset managers, registrars, private client wealth managers and private banks. | Sales & Marketing | 01/01/2019 |
Nomura Code Securities Ltd. | Analyst-Equity | 17/07/2009 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
RENEURON GROUP PLC | Health Technology |
OXFORD BIOMEDICA PLC | Health Technology |
BENEVOLENTAI | Health Technology |
Entreprise privées | 2 |
---|---|
Nomura Code Securities Ltd. | Finance |
Peel Hunt LLP
Peel Hunt LLP Investment Banks/BrokersFinance Peel Hunt LLP is an independent securities brokerage firm headquartered in London, UK. The firm was founded in 1989 as a market liquidity provider to retail and institutional investors. They provide bespoke dealing and execution services for institutional asset managers, registrars, private client wealth managers and private banks. | Finance |